Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom
On April 9, 2026, Health Canada issued a public advisory warning consumers about unauthorized injectable peptide drugs, naming BPC-157 among the products it has seized
A study frequently mentioned in our studies [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] was a multicenter, randomized, double-blind, placebo-controlled study [257], which was performed to assess the efficacy, safety, and pharmacokinetics of BPC 157 in patients with mild to moderate ulcerative colitis
5 out of 5 starsReviewed on 9/8/2025 Very professional
Whether youre considering GLP-1 medications, exploring short-term options, or wondering if surgery is a more lasting solution, Grand Health Partners is here to guide you every step of the way